Somatic mutation webinar
-
Upload
elsa-von-licy -
Category
Documents
-
view
209 -
download
0
Transcript of Somatic mutation webinar
Sample & Assay Technologies- 1 -
qBiomarker ™ Somatic Mutation PCR Arrays
Cancer Mutation Analysis Made Easy
Shankar Sellappan, Ph.DGlobal Product Manager
Sample & Assay Technologies- 2 -
Legal Disclaimer
• SABiosciences products are intended for molecular b iology applications. These products are not intended for the diagnosis, prevention, or treatment of a disease.
• For up-to-date licensing information and product-sp ecific disclaimers, see the respective QIAGEN kit handbook or user manual. QIAGEN kit handbooks and user manuals are available at www.QIAGEN.com or can be requested from QIAGEN Technical Services or your local distri butor.
Sample & Assay Technologies- 3 -
• SABiosciences is now a Company
Welcome to SABiosciences: Who We Are
Sample & Assay Technologies- 4 -
Table of Contents
• DNA Mutations Overview
• What is a qBiomarker Somatic Mutation PCR Array?
� How to Analyze Samples for DNA Mutations
• Workflow for qBiomarker Somatic Mutation PCR Arrays
• How qBiomarker Somatic Mutation PCR Assays Work
• Data Analysis
• How to Order
Sample & Assay Technologies- 5 -
What is a Somatic DNA Mutation?
� Definition� Alterations in DNA that can occur in any of the cel ls of the
body except germ cells– NOT passed on to children
� Single Point Mutation or Multiple Mutations Possibl e within a Gene
Sample & Assay Technologies- 6 -
Somatic Mutations vs Single Nucleotide Polymorphisms (SNPs)
• Somatic Mutations occur in cells that are NOT passed down to children
• SNPs occur in Germline cells (that ARE passed down)
• What is important in SNP analysis is the Allele Frequency
• Which means how often it occurs
Note: qBiomarker Somatic Mutation PCR Arrays & Assays only show the Presence of a Mutation
� Qualitative, not Quantitative Information
� Quantitative may come in future.
Sample & Assay Technologies- 7 -
�Changes in a single or multiple nucleotides within a gene, or across related genes in a pathway, may alter the resulting protein, either by activity level or functional ability, resulting in:� Cancers
� Cardiovascular diseases (Arrhythmia)� Blood/hematologic disorders
Physiological Implications of DNA Mutations
Sample & Assay Technologies- 8 -
Implications of DNA Mutations in Drug Development
�Drug compounds may behave differently in a similar profile of sample, based on Somatic Mutation profile.� Ex. 30% of Breast Cancers overexpress HER2.
–However, not all respond to HER2 therapy (i.e. Herceptin®)
• This may indicate a different HER2 mutation occurring in samples, thereby yielding different outcomes.
Sample & Assay Technologies- 9 -
How do DNA Mutations Occur?
• Copying Errors
• as part of Replication Process
• Estimated Error Rate of DNA Polymerase: 1 in 108 bases
• Human Genome = 2.9 billion bases (2.9 x 109 bases)
• DNA Damage
• Resulting from Environmental Agents, such as:
• Sunlight (UV)
• Cigarette Smoke
• Radiation
Sample & Assay Technologies- 10 -
What Kinds of DNA Mutations are There?
• Point Mutation
• A � G
• Frame Shift Mutation / Insertion / Duplication
• ACGTACGTC
• ACGATACGTC
• Deletion
• ACGTACGTC
• ACGACGTC
• Inversion
• ACGTACGTC
• ACTGACGTC
• ACGTACGTC
• ACGAGGTACGTC
• ACGTACGTC
• ACGTACTACGTC
From 1 – 100s of bases
Sample & Assay Technologies- 11 -
How many DNA Mutations have been identified?
• ~ 140,000 DNA Mutations Identified
• Most DNA Mutations NOT Functionally Relevant at the Protein Level
• Multiple Consortiums
• COSMIC: Catalog of Somatic Mutations in Cancer: Sanger Institute
• HGMD: The Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff
• dbRBC: Blood Group Antigen Gene Mutation Database: NCBI
• EXPECTATIONS � IMPORTANT POINT TO REMEMBER
• Cells under study may contain one to a few mutations as assayed for on a pathway-focused qBiomarker Somatic Mutation PCR Array
Sample & Assay Technologies- 12 -
Table of Contents
• DNA Mutations Overview
• What is a qBiomarker Somatic Mutation PCR Array?
� How to Analyze Samples for DNA Mutations
• Workflow for qBiomarker Somatic Mutation PCR Arrays
• How qBiomarker Somatic Mutation PCR Assays Work
• Data Analysis
• How to Order
Sample & Assay Technologies- 13 -
What is a Somatic Mutation PCR Array?
Somatic Mutation PCR Array
• Definition: Collection of mutation specific assays for multiple mutations in a single gene, as well as mutations present in g enes in downstream signaling activities
• Example: EGFR Pathway Somatic Mutation PCR Array
• EGFR Mutations: 29 Different mutations present in t he EGFR gene
• AKT1 Mutations: 1
• BRAF Mutations: 12
• KRAS Mutations: 18
• HRAS Mutations: 11
• NRAS Mutations: 12
• MEK1 Mutations: 4
• PI3K Mutations: 7
• PTEN Mutations: 6
Sample & Assay Technologies- 14 -
Why Study Somatic Mutations in a Pathway Array?
EGFR Mutations
AKT1 Mutations
BRAF Mutations
KRAS Mutations
HRAS Mutations
NRAS Mutations
MEK1 Mutations
PI3K Mutations
PTEN Mutations
Sample & Assay Technologies- 15 -
What is the Layout of a qB Somatic Mutation PCR Arra y?
Greek Symbol = Gene
# = Mutation
• For Normalization
• Assays detect non-variable region (not ARMS-based design)
• Designed to control differences in sample input and quality
Sample & Assay Technologies- 16 -
Array Layout: Example: EGFR Pathway
Sample & Assay Technologies- 17 -
qBiomarker Cancer Somatic Mutation PCR ArraysAvailable Pathways
• EGFR pathway (lung cancer, colorectal cancer, glioblastoma multiforme)
• ERBB2 (HER-2/neu) pathway (breast cancer, lung, gastric cancers)
• PDGFR pathway (GIST, glioblastoma, prostate cancer)
• FLT3 pathway (acute meyloid leukemia (AML))
• RTK I & II (96-well) or RTK-HT (384-well)
• KIT pathway (leukemia, gastrointestinal stromal, testicular germ cell tumors)
• MET pathway (kidney, liver, stomach, breast and brain cancers)
• FGFR pathway (leukemia and multiple myeloma)
• Upcoming:
•PI3K pathway (one of the most commonly activated pathways in cancer)
• P53-Rb pathways (associated with resistance to multiple chemo-therapeutic drugs)
• ββββ-Catenin/CTNNB1-APC pathway (colon, prostate, uterine cancers)
Sample & Assay Technologies- 18 -
Table of Contents
• DNA Mutations Overview
• What is a qBiomarker Somatic Mutation PCR Array?
� How to Analyze Samples for DNA Mutations
• Workflow for qBiomarker Somatic Mutation PCR Arrays
• How qBiomarker Somatic Mutation PCR Assays Work
• Data Analysis
• How to Order
Sample & Assay Technologies- 19 -
Analysis Methods for DNA Mutations
SensitivityProtocol complexNeed Instrument/Training
Large CoverageMicroarray
Time ConsumingNeed Instrument/Training
ExactMass Spectrometry
Base change identity not obvious
InexpensiveFastSimple
High Resolution Melt
Time ConsumingNeed Instrument/Training
ExactNext-Generation Sequencing
FastReliableHigh-throughput
Quantify DNA Targets� Real-time PCR
Time ConsumingExactPoint Mutation Analysis
DrawbacksBenefitsMethod
Sample & Assay Technologies- 20 -
Sensitivity of Mutation ID Technologies / Principle s
Measurement of Sensitivity:
In a population of 100 total cells, sensitivity of:
• RT-PCR (PCR Arrays): 1-2%• 1-2 mutant DNA + 98-99 wild-type DNA
• Pyromark Sequencing: 5%• 5 mutant DNA + 95 wild-type DNA• Method of DNA sequencing based on the “sequencing by synthesis principle”
• Sequenom/Microarray: 10%• 10 mutant DNA + 90 wild-type DNA
Sample & Assay Technologies- 21 -
qBiomarker Somatic Mutation Assay Detection Limit
Assay detection limit test for qBiomarker Braf V600E assay. A series of 10ng genomic DNA samples, which contain genomic DNA from A375 cell line mixed with WT genomic DNA at different ratios, were tested on qBiomarker Somatic Mutation Assay for Braf V600E with or without whole genome amplification. Mutation detection limit for this assay is determined to be ~1%.
WGA = Whole Genome Amplification
Sample & Assay Technologies- 22 -
Table of Contents
• DNA Mutations Overview
• What is a qBiomarker Somatic Mutation PCR Array?
� How to Analyze Samples for DNA Mutations
• Workflow for qBiomarker Somatic Mutation PCR Arrays
• How qBiomarker Somatic Mutation PCR Assays Work
• Data Analysis
• How to Order
Sample & Assay Technologies- 23 -
DNA Sample Requirement
• If less than 5 ng DNA available from Fresh frozen samples, Whole Genome Amplification recommended.
NOTE: WGA NOT recommended for FFPE samples
Sample & Assay Technologies- 24 -
How do qBiomarker Somatic Mutation Arrays Work?
Fresh/frozen samples: 200 – 500 ng gDNA
FFPE samples: 200 – 500 ng gDNA
Fresh/frozen samples: 5 – 10 ng gDNA
Sample & Assay Technologies- 25 -
Table of Contents
• DNA Mutations Overview
• What is a qBiomarker Somatic Mutation PCR Array?
� How to Analyze Samples for DNA Mutations
• Workflow for qBiomarker Somatic Mutation PCR Arrays
• How qBiomarker Somatic Mutation PCR Assays Work
• Data Analysis
• How to Order
Sample & Assay Technologies- 26 -
How do qBiomarker Somatic Mutation Assays Work?
. Hydrolysis Probe Assays + ARMS
Sample & Assay Technologies- 27 -
. Relies on the 5’ – 3’ exonuclease activity of the Taq activity of Taq Polymerase� The Exonuclease Activity degrades a hybridized non-extendable DNA probe during
the extension step of the PCR.� DNA Probe: Hybridizes to a region within the amplicon and is dual-labeled with a
reporter dye and quenching dye.
Definition: Hydrolysis Probes & Assays
Sample & Assay Technologies- 28 -
Definition: Allele Specific Amplification with ARMS ®
ARMS: Amplification Refractory Mutation System
� Strategy in which Primers Discriminate Among Templates Differing by a Single Nucleotide
� Oligos with a mismatched 3’-residue WILL NOT FUNCTIONas Primers in a PCR Reaction
� But with the 3’-residue matching at the exact spot of the mutation
Sample & Assay Technologies- 29 -
Primer Elongation & Probe Activation with ARMS ®
F Q
F Q
Common Region
Sample & Assay Technologies- 30 -
Key to qBiomarker Somatic Mutation Assay Design
� Additional mismatch used� Mutation Position & Additional Mutation
– 1-3 bp near mutation site (location is proprietary)� Increases specificity
Sample & Assay Technologies- 31 -
Allele Specific Amplification with ARMS ®
ARMS: A Closer Look
AGTCAGTCTemplate: Wild-TypeMutation Locus:
C is correct for WT
TCAGTAAAARMS Mutation Primer
}Won’t WorkARMS Mutation
Add’l Mutation: Location Varies
AGTCAGTTTemplate: MutationTCAGTAAAARMS Mutation Primer
Mutation Locus:
C is correct for WT
}Will Work
Why this works: Internal Mismatches: Enzyme Requirement Less Stringent
Sample & Assay Technologies- 32 -
Why ARMS + Hydrolysis Probe? Why not just Hydrolysis Probe?
� Hydrolysis Probes� Measures just target strand abundance
� ARMS (Amplification Refractory Mutation System)� Preferentially amplifies the mutant alleles
– We are trying to detect as low as 1-2% somatic mutation in a wild-type DNA background
- ARMS – designed primers will preferentially amplify the mutant sequence
Sample & Assay Technologies- 33 -
Mutations
FFPE Samples
KRAS∆Ct
Notice how each FFPE sample harbors only 1 or two mutations
���� So we are NOT looking for spikes everywhere
qBiomarker Somatic Mutation ArrayDetection of BRAF, EGFR, and KRAS Mutations
• Samples: Asian, Female, non-smoker origin; Lung Adenocarcinoma
• Expected: 30% Mutation in EGFR
BRAF
EGFR
Sample & Assay Technologies- 34 -
qBiomarker Somatic Mutation Assay ValidationPyrosequencing Confirmation of KRAS & EGFR Mutations
Sample & Assay Technologies- 35 -
Table of Contents
• DNA Mutations Overview
• What is a qBiomarker Somatic Mutation PCR Array?
� How to Analyze Samples for DNA Mutations
• Workflow for qBiomarker Somatic Mutation PCR Arrays
• How qBiomarker Somatic Mutation PCR Assays Work
• Data Analysis
• How to Order
Sample & Assay Technologies- 36 -
Somatic Mutation PCR Array Data Analysis
• Purpose: Qualitative assessment of samples
• Is the DNA Mutation Present and if so, which one?
• Data Analysis Methods depends on:
• 1. Availability of wild-type sample
• 2. Sample type/quality
• Cell lines
• Fresh or frozen samples
• FFPE samples
• 3. How many samples?
• NOTE: Compare Presence of Same Mutant Assay Across Samples
• NOTE: Each sample harbors only a single or at most few mutations
Sample & Assay Technologies- 37 -
qBiomarker Somatic Mutation PCR Array Data AnalysisAverage C t Method
Recommended for experiments using:
• FFPE samples
• Large #s of samples (> 4)
• Wide range of sample quality
• Wild-type controls not necessary
• Assumes that for a given locus, mutation occurs in small % of samples.
∴∴∴∴Ctaverage
= Mutation Assay Background in Wild-Type Sample
�Compare C tsample
to C taverage
= ∆Ct
� If Ctsample
<< Ctaverage
���� Sample has Mutation
Sample & Assay Technologies- 38 -
Average C t method examples
.FFPE cell line samples� Lung Cancer & Colon Cancer cell lines� MDA-MB-231 as a positive control
� G464V Braf and G13D Kras mutation status gathered from COSMIC database and confirmed by:
– DxS Kras PCR test– Braf Pyrosequencing assay
.9 FFPE lung cancer samples, 1 placenta FFPE sample� Sample origin
� Adenocarcinoma� Expected EGFR mutation rate: ~10%
Sample & Assay Technologies- 39 -
Average C t: Example Data: Collaboration: ββββ-TestMutation Profiling of FFPE Samples on EGFR PCR Arra y
Conclusion of the ββββ-testThe two known mutations in MDA-MB-231 cell line FFPE sample were correctly called: 2 Kras and 1 EGFR mutation (~10%) called in 3 lung cancer FFPE samples.
∆Ct
Mutation
Cancer C
ell Lines
Sample & Assay Technologies- 40 -
� Tested 10 FFPE adenocarcinoma samples
� Expect high % (>30%) EGFR activating mutations (point mutation & deletions)
� Paez et al. Science. (2004) 304:1497-500
Ad
enocaecrinoma
Mutation
∆Ct
Average C t: Example Data: In-House DataMutation Profiling of FFPE Samples on EGFR PCR Arra y
Sample & Assay Technologies- 41 -
qBiomarker Somatic Mutation PCR Array Data Analysis∆∆Ct Method
Recommended for experiments using:
• Small #s of samples (< 4)
• Basic Cell Line Experiments….Looking for Mutation in just a couple of cell line samples
• Results affected by sample quality (Wild-type and Test Samples)
• Wild-type controls NECESSARY
• Wild-type controls MUST be of high-quality
• Considers Copy # Changes
• NORMALIZES (∆Ct)
• Caveats
• Penalizes good quality samples (False Negatives)
• Rewards bad quality samples (False Positives)
Sample & Assay Technologies- 42 -
qBiomarker Somatic Mutation PCR Array Data Analysis∆∆Ct Method
* A raw Ct cutoff for Ct (sample locus X) will be applied (usually 35); If sample Ct > cutoff Ct, the sample will NOT be called “mutant” for that locus
Normalized Ct For Allele/Mutation Site = ∆Ct = CtMUT – Ct
CNA
27
28
CNA
3
12
∆Ct
30Mutant
40WT
Mutation Assay
���� ∆∆Ct = 9
Sample & Assay Technologies- 43 -
∆∆∆∆∆∆∆∆Ct Method: ExampleEGFR Pathway: Cancer Cell Lines (200 ng gDNA)
Mutation
Can
cer
Cel
l Lin
es
Sample & Assay Technologies- 44 -
Data Analysis Method Selection Summary• ∆∆Ct method
• Must have wild-type control• Works well for projects using:
• Fresh/frozen samples• Smaller (≤4) number of samples
• i.e. sample quality similar
• Average Ct method• Works well for projects using:
• FFPE samples• Large number of samples
• i.e. sample quality can be in a wide range• Without Wild-type controls
qBiomarker Somatic Mutation PCR Array Data AnalysisTwo Methods: ∆∆Ct vs Average C t: How to Choose
Sample & Assay Technologies- 45 -
Data Analysis: Excel Files: Pathway-Specific
Sample & Assay Technologies- 46 -
Table of Contents
• DNA Mutations Overview
• What is a qBiomarker Somatic Mutation PCR Array?
� How to Analyze Samples for DNA Mutations
• Workflow for qBiomarker Somatic Mutation PCR Arrays
• How qBiomarker Somatic Mutation PCR Assays Work
• Data Analysis
• How to Order
Sample & Assay Technologies- 47 -
qBiomarker Somatic Mutation: Product Availability
337021: qBiomarker Somatic Mutation PCR Arrays
337011: qBiomarker Somatic Mutation PCR Mutation Assays100 reactions
•NOTE: Corresponding qBiomarker Probe Master Mixes are included with ALL ORDERS.
• Please visit http://sabiosciences.com/somaticmutationarray.php for the most up-to-date list of Pathway/Disease Focused Somatic Mutatio n PCR Arrays
Sample & Assay Technologies- 48 -
E-Learning Center:Recorded Seminars
Additional Resources
Sample & Assay Technologies- 49 -
qBiomarker™ Somatic Mutation PCR Arrays & Assays
Shankar Sellappan, Ph.D.Global Product Manager